Expands: Expanding ploidy and allele frequency on nested subpopulations

Bioinformatics

Volumn 30, Issue 1, 2014, Pages 50-60

  Andor, Noemi ^a,b,c   Harness, Julie V ^a,c   Müller, Sabine ^a,c   Mewes, Hans W ^b,d   Petritsch, Claudia ^a,c,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENE FREQUENCY; GENETICS; GLIOBLASTOMA; HUMAN; MUTATION; NEOPLASM; PATHOLOGY; PLOIDY; PROBABILITY; RECURRENT DISEASE;

GENE FREQUENCY; GLIOBLASTOMA; HUMANS; MUTATION; NEOPLASMS; PLOIDIES; PROBABILITY; RECURRENCE;

EID: 84891370404     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btt622     Document Type: Article

References (26)

1. Aktipis, C.A. et al. (2011) Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research. PLoS One, 6, e26100.
2. Anderson, K. et al. (2011) Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature, 469, 356-361.
3. Carter, S.L. et al. (2012) Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotech., 30, 413-421.
4. Chen, J. et al. (2012) A restricted cell population propagates glioblastoma growth after chemotherapy. Nature, 488, 522-526.
5. Fan, Q.-W. et al. (2010) Akt and autophagy cooperate to promote survival of drugresistant glioma. Sci. Signal., 3, ra81.
6. Harada, K. et al. (1998) Intratumoral cytogenetic heterogeneity detected by comparative genomic hybridization and laser scanning cytometry in human gliomas. Cancer Res., 58, 4694-4700.
7. Inda, M.-M. et al. (2010) Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. Genes Dev., 24, 1731-1745.
8. Konishi, Y. et al. (2012) Patterns of intracranial glioblastoma recurrence after aggressive surgical resection and adjuvant management: retrospective analysis of 43 cases. Neurol. Med. Chir. (Tokyo), 52, 577-586.
9. Lawrence, M.S. et al. (2013) Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature, 499, 214-218.
10. Little, S.E. et al. (2012) Receptor tyrosine kinase genes amplified in glioblastoma exhibit a mutual exclusivity in variable proportions reflective of individual tumor heterogeneity. Cancer Res., 72, 1614-1620.
11. Lomonaco, S.L. et al. (2009) The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells. Int. J. Cancer, 125, 717-722.
12. Merlo, L.M.F. andMaley, C.C. (2010) The role of genetic diversity in cancer. J. Clin. Invest., 120, 401-403.
13. Merlo, L.M.F. et al. (2010) A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma. Cancer Prev. Res. (Phila), 3, 1388-1397.
14. Mroz, E.A. et al. (2013) High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma. Cancer, 119, 3034-3042.
15. Navin, N. et al. (2011) Tumour evolution inferred by single-cell sequencing. Nature, 472, 90-94.
16. Nik-Zainal, S. et al. (2012) The life history of 21 breast cancers. Cell, 149, 994-1007.
17. Nowell, P.C. (1976) The clonal evolution of tumor cell populations. Science, 194, 23-28.
18. Pruitt, K.D. et al. (2012) NCBI Reference Sequences (RefSeq): current status, new features and genome annotation policy. Nucleic Acids Res., 40, D130-D135.
19. Sathirapongsasuti, J.F. et al. (2011) Exome sequencing-based copy-number variation and loss of heterozygosity detection: exomeCNV. Bioinformatics, 27, 2648-2654.
20. Schonberg, D.L. et al. (2013) Brain tumor stem cells: molecular characteristics and their impact on therapy. Mol. Aspects Med., [Epub ahead of print, July 4, 2013].
21. Shah, S.P. et al. (2012) The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature, 486, 395-399.
22. Snuderl, M. et al. (2011) Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. Cancer Cell, 20, 810-817.
23. Sottoriva, A. et al. (2013) Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc. Natl Acad. Sci. USA, 110, 4009-4014.
24. Stupp, R. et al. (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol., 10, 459-466.
25. Szerlip, N.J. et al. (2012) Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response. Proc. Natl Acad. Sci. USA, 109, 3041-3046.
26. Tolliver, D. et al. (2010) Robust unmixing of tumor states in array comparative genomic hybridization data. Bioinformatics, 26, i106-i114.